Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease

Keyphrases

• Targeted Therapy 100%
• Graft-versus-host Disease (GvHD) 100%
• Clinical Trials 50%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 50%
• Steroid-refractory Graft-versus-host Disease 50%
• High Dose 25%
• T Cells 25%
• Mechanism of Action 25%
• Major Complications 25%
• Protease Inhibitors 25%
• Treatment Failure 25%
• Tyrosine Kinase Inhibitor 25%
• First Treatment 25%
• Drug Administration 25%
• Non-relapse Mortality 25%
• Systemic Steroids 25%
• Ruxolitinib 25%
• PubMed Database 25%

Immunology and Microbiology

• Graft-Versus-Host Disease 100%
• Acute Graft Versus Host Disease 100%
• Hematopoietic Cell 50%
• Drug Megadose 25%
• T Cell 25%
• Medline 25%
• Proteasome 25%
• Target Tissue 25%
• Immunology 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Graft Versus Host Reaction 100%
• Acute Graft Versus Host Disease 100%
• Clinical Trial 50%
• Protein Tyrosine Kinase Inhibitor 25%
• Proteasome Inhibitor 25%
• Drug Administration 25%
• Ruxolitinib 25%